Beijing Beilu Pharmaceutical
Beijing · Founded 1992
About Beijing Beilu Pharmaceutical
Beijing Beilu Pharmaceutical mainly engaged in the research and development, production, and sales of pharmaceutical products. It is a national high-tech enterprise, one of the first batch of listed enterprises in Growth Enterprises Market (stock code 300016), and a leading contrast agent enterprise. Beilu is the first company to develop and launch the contrast agent products in China, filling the gap in the domestic market, and forming a unique core competitive advantage in this field is the market leader in the domestic contrast agent industry. In addition, the company has also strengthened R&D in the field of psychoneurosis and endocrinology drugs, and strive to achieve variety diversification.
Company Facts
- Founded: 1992
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Total funding: $9.7M
- Funding stage: IPO
- Last round: Private Equity (Aug 2008)
- Ticker: szse:300016
- Website: beilu.com.cnbeilu-sc
Social Profiles
Canonical: https://fsome.com/organization/beijing-beilu-pharmaceutical-2324061 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.